Clicky

IsoRay, Inc.(ISR)

Description: IsoRay, Inc. engages in the development, manufacture, and sale of isotope-based medical products and devices for the treatment of cancer and other malignant diseases primarily in the United States. The company produces Proxcelan Cesium-131 brachytherapy seeds that are used for the treatment of prostate cancer; ocular melanoma; head, neck, and lung tumors; breast cancer; liver cancer; brain cancer; colorectal cancer; gynecological cancer; esophageal cancer; and pancreatic cancers. It also offers GliaSite radiation therapy system, a balloon catheter device, which is used to treat brain cancer. IsoRay, Inc. is based in Richland, Washington.


Keywords: Medicine Cancer Oncology Treatment Of Cancer Radiation Breast Cancer Prostate Cancer Catheter Medical Physics Melanoma Colorectal Cancer Radiation Therapy Pancreatic Cancer Treatment Of Breast Cancer Medical Products Liver Cancer Brain Cancer Treatment Of Prostate Cancer Esophageal Cancer Balloon Catheter Brachytherapy Ocular Melanoma

Home Page: isoray.com

ISR Technical Analysis

350 Hills Street
Richland, WA 99354
United States
Phone: 509 375 1202


Officers

Name Title
Ms. Lori A. Holmes-Woods CEO & Director
Ms. Jennifer Streeter COO & VP of HR
Mr. William A. Cavanagh III Chief R&D Officer
Mr. Jonathan R. Hunt CFO & Co-Principal Financial Officer
Mr. Mark J. Austin CPA VP of Fin., Controller, Co-Principal Financial, Principal Accounting Officer & Sec.
Ms. Krista Cline Sr. Director of Operations & Corp. Sec.

Exchange: NYSE MKT

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 0.7389
Price-to-Sales TTM: 4.1428
IPO Date: 2005-11-10
Fiscal Year End: June
Full Time Employees: 66
Back to stocks